Homechevron_rightArchiveschevron_rightHealth

Archives

Explore Stories by Date

19 Jun 2026

AI discovers hidden antibiotic candidates inside prion proteins linked to brain diseases

Researchers at the University of Pennsylvania used AI to uncover a surprising source of antibiotics: prion proteins known for causing fatal brain diseases. The deep-learning platform identified over 1,000 antimicrobial peptides called prionins, with dozens showing strong activity against drug-resistant bacteria in lab and mouse tests.

2 Sources

AI helps Boston Children's Hospital diagnose 18 kids whose rare diseases stumped doctors for years

Boston Children's Hospital partnered with OpenAI to analyze 376 unsolved pediatric cases, leading to 18 new rare disease diagnoses. The o3 model synthesized genetic data and medical literature to identify conditions including neurodevelopmental disorders and neuromuscular diseases. OpenAI has committed $50 million to support the hospital's AI initiatives, which have already saved 60,000 hours of work valued at over $7 million.

2 Sources

Ultrahuman M2 Live brings affordable metabolic health tracking to US consumers at $99 per month

Ultrahuman has launched M2 Live in the United States, making continuous glucose monitoring accessible to non-diabetic consumers. The platform integrates Abbott's over-the-counter Lingo CGM with AI-powered health insights, starting at $99 per month. It combines glucose data with sleep, activity, and biomarker tracking to provide comprehensive metabolic health monitoring.

2 Sources

18 Jun 2026

Deep learning identifies promising antibiotic candidates against drug-resistant gonorrhea

Researchers at Harvard's Wyss Institute used deep learning to screen 6 million compounds and identified two promising candidates against multi-drug resistant Neisseria gonorrhoeae. The lead compound, called A1, targets alanine racemase, an enzyme critical for bacterial cell wall formation. The study marks the first use of Organ Chip technology for antibiotic preclinical testing, offering a faster validation pipeline.

2 Sources

Midjourney Scanner promises MRI-quality scans in 60 seconds, but lacks FDA approval

Midjourney, the AI image generator company, unveiled its first hardware product: a full-body scanner using ultrasound technology that claims to deliver MRI-comparable results in about 60 seconds. CEO David Holz revealed plans for Midjourney Medical and a San Francisco spa housing the scanners. However, the device currently lacks FDA clearance and has no proven track record in medical diagnostics.

8 Sources

77% of Psychologists Report Patients Using AI Chatbots for Mental Health Support, APA Survey Finds

A new American Psychological Association survey of over 1,200 licensed psychologists reveals that three-quarters have patients using AI chatbots for emotional support, self-diagnosis, and companionship. While some report positive outcomes, 36% of psychologists noticed patients developing dependency on chatbots, and 15% observed distorted thinking or delusions.

2 Sources

17 Jun 2026

Stanford grads raise $11M to build noninvasive wearable for continuous hormone tracking

Clair Health, founded by 21-year-old Jenny Duan and Abhinav Agarwal, secured $11.6 million in seed funding led by Khosla Ventures to develop what they call the first continuous non-invasive hormone monitor for women. The wearable uses 10 biosensors including a novel biomagnetic sensor to track hormonal health, targeting conditions like perimenopause, PCOS, and endometriosis with a November launch planned at $369.

2 Sources

AI analyzes retinal photos to predict Alzheimer's disease risk decades before symptoms appear

University of Florida researchers trained machine learning models on retinal photographs from over 40,000 patients to identify early Alzheimer's disease risk factors. The AI-powered analysis detected biological and lifestyle indicators like blood pressure, smoking, and insomnia by examining the retina's arteries and optic nerve, offering a low-cost alternative to expensive brain scans.

2 Sources

JMIR Publications explores AI clinical reasoning and digital fatigue in modern healthcare

JMIR Publications released two feature stories examining AI's role in healthcare. One explores how OpenAI's o1 model matched physician performance in clinical decision-making across three care stages. The other investigates digital fatigue in modern health care, where administrative burdens from digital systems contribute to healthcare worker burnout despite automation benefits.

2 Sources

16 Jun 2026

Brain-Computer Interface and AI Let Speechless ALS Patient Speak and Work Full-Time

A UC Davis brain-computer interface has enabled Casey Harrell, a paralyzed ALS patient, to communicate independently for over 3,800 hours across two years with 99% accuracy in controlled tests. Using AI-driven speech synthesis, the BCI implant translates neural activity into speech, allowing him to work full-time as an environmental advocate and have conversations with his daughter who's never heard his voice.

2 Sources

AI-powered deep brain stimulation adapts in real time to improve gait in Parkinson's disease

Researchers have developed adaptive deep brain stimulation that adjusts electrical pulses in real time based on patient movement. The system uses machine learning to decode brain signals during walking, standing, and obstacle navigation, delivering personalized neuromodulation that improves walking in Parkinson's patients where conventional therapies fall short.

3 Sources

15 Jun 2026

Family blames AI hospital system after woman dies waiting five days for ICU bed in Brazil

A 32-year-old Brazilian woman died after an AI-powered hospital management system allegedly delayed her ICU transfer for five days. Rebeca Cardoso Tenente Molina's family claims the Core-MG system assigned her a lower severity score than her deteriorating condition warranted, preventing doctors from exercising their medical judgment. The case highlights concerns about AI decision-making in critical healthcare situations.

2 Sources

11 Jun 2026

Takeda's AI-developed psoriasis pill outperforms Bristol Myers' Sotyktu in head-to-head trial

Takeda Pharmaceutical announced its AI-crafted experimental psoriasis drug zasocitinib achieved superior skin clearance compared to Bristol Myers' approved Sotyktu in a late-stage study. The once-daily pill delivered complete skin clearance in 35% of patients after 16 weeks, more than 2.5 times Sotyktu's rate, positioning it as a potential blockbuster with projected peak annual sales of $3-6 billion.

2 Sources

Abridge and Nvidia build foundation model for clinical intelligence from real doctor visits

Abridge unveiled an AI-native clinician intelligence platform with backing from Nvidia and Eli Lilly, transforming ambient AI from a transcription tool into an operating system for medicine. The startup now processes 100 million clinical conversations annually across 300+ health systems, while co-developing the first foundation model trained specifically on doctor-patient dialogue.

3 Sources

10 Jun 2026

Hetairos AI classifies brain tumors in 12 minutes with 87% accuracy, outperforming specialists

Researchers at the German Cancer Research Center have developed Hetairos, an AI system that identifies over 100 molecular subtypes of brain tumors using standard microscopic tissue sections. Trained on more than 11,000 slides from 9,606 patients across four continents, the system delivers diagnoses in 12 minutes with 87% accuracy—significantly outperforming experienced neuropathologists in head-to-head testing.

2 Sources

Get all updates into your inbox 💌, Stay Up-to-date for Free 🥳

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.

Explore

News Categories

Technology Business Policy Startups Health Science Entertainment

Terms Privacy Content Contact Us